Dasatinib–Blinatumomab for Ph-Positive ALL

  • Kamachi, Kazuharu M.D.
  • Ureshino, Hiroshi M.D., Ph.D.

No potential conflict of interest relevant to this letter was reported.

New England Journal of Medicine 384(4):p 384, January 28, 2021. | DOI: 10.1056/NEJMc2033785

Dasatinib–Blinatumomab for Ph-Positive Acute Lymphoblastic Leukemia in Adults

  • Foà, Robin M.D.
  • Bassan, Renato M.D.
  • Vitale, Antonella M.D.
  • Elia, Loredana M.D.
  • Piciocchi, Alfonso M.S.
  • Puzzolo, Maria-Cristina Ph.D.
  • Canichella, Martina M.D.
  • Viero, Piera M.D.
  • Ferrara, Felicetto M.D.
  • Lunghi, Monia M.D.
  • Fabbiano, Francesco M.D.
  • Bonifacio, Massimiliano M.D.
  • Fracchiolla, Nicola M.D.
  • Di Bartolomeo, Paolo M.D.
  • Mancino, Alessandra M.S.
  • De Propris, Maria-Stefania Ph.D.
  • Vignetti, Marco M.D.
  • Guarini, Anna Ph.D.
  • Rambaldi, Alessandro M.D.
  • Chiaretti, Sabina M.D., Ph.D.
New England Journal of Medicine 383(17):p 1613-1623, October 22, 2020. | DOI: 10.1056/NEJMoa2016272
Copyright © 2021 Massachusetts Medical Society. All rights reserved.